LAUREL DIMAGGIO: Open Payments
NPI 1053718395 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 15 payments from 10 companies in 2025. Trend: 2023 $707 · 2024 $467 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| ABIOMED | 2 | $87 |
| Edwards Lifesciences Corporation | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Cleerly, Inc. | 1 | $29 |
| ConvaTec Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: NAVITOR, LEQVIO, SAPIEN 3 Ultra RESILIA, ONPATTRO, Cleerly Ischemia, AQUACEL AG+, Korlym, VYNDAQEL.
Industry payments across FL — which companies pay providers there.
